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case and propose a surgical technique, used in our case, 
useful in prevention of the recurrence of twiddler's yn- 
drome. 
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Congenital heart diseases (CHD) are often accompa- 
nied by pulmonary hypertension (PH), and the severity of 
PH is an important determinant of the prognosis of such 
patients. 1 Endothelin-1 (ET-1), an endothelium-derived 
peptide, has potent contractile and proliferative effects on 
vascular smooth muscle cells. 2' 3 Elevated plasma concen- 
tration of ET-1 has been reported in patients with PH of 
4 5 bothprimary and secondary forms. Yoshibayashi, Vin- 
cent,~ and their associates have reported that plasma ET-1 
levels are elevated in patients with PH caused by CHD. 
Elevated plasma ET-1 concentrations have also been 
reported in rats with experimentally induced PH, and an 
endothelin receptor antagonist effectively attenuated the 
development of PH in the rats] These observations suggest 
that endogenous ET-1 may have an important role in the 
increased pulmonary vascular tonus or medial hypertrophy 
of the pulmonary blood vessels in patients with PH. How- 
ever, no information is available regarding whether elevated 
plasma ET-1 is altered by amelioration of clinical status of 
PH. The aim of the present study is to investigate whether 
elevated plasma ET-1 in young patients with PH caused by 
CHD changes after surgical repair for CHD. 
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Eleven patients with PH caused by CHD were studied. 
Their ages were 6.7 + 1.2 (mean _+ standard error of the 
mean) months at operation. Their diagnoses were ventric- 
ular septal defect in six patients, total anomalous pulmo- 
nary venous drainage in two, cor triatriatum in one, and 
pulmon~iry venous tenosis after repair of total anomalous 
pulmonary venOus drainage in two. Informed consent was 
obtained from the parents of each patient enrolled for the 
study. On all the patients, surgical repair (tota ! correction) 
was successful. Before and 4 weeks after the operation, 
percutaneous cardiac atheterization via the femoral vein 
was performed with routine sedation. Six patients with 
anatomically normal hearts and normal hemodynamics 
without PH served as controls; their ages were 11.0 + 2.5 
months. The blood samples (4 ml of whole blood) were 
obtained from the inferior vena cava for analysis of 
plasma ET-1 levels. The samples were placed into chilled 
tubes containing sodium ethylenediaminetetraacetate and 
aprotinin. Plasma ET-1 levels were measured by a sand- 
wich-enzyme immunoassay as previously described, s'9 
Data were expressed as mean -+ standard error of the 
mean. The significance of difference was analyzed by 
paired/unpaired Student's t test. A P value less than 0.05 
was considered statistically significant. 
In all the patients with PH, surgical repair for CHD was 
performed successfully, and the hemodynamic states of 
the pulmonary circulation 4 weeks after the operation 
were greatly improved; that is, the operation significantly 
decreased systolic pulmonary blood pressure (73.8 _+ 4.7 
mm Hg to 39.0 +- 4.7 mm Hg, n = 11, p < 0.001), total 
pulmonary vascular esistance index (12.2 +_ 0.3 unit. m 2 
to 5.6 • 1.2 un i t .m 2, n = 11, p < 0.05), and mean 
pulmonary arterial wedge pressure (17.0 + 2.8 mm Hg to 
8.0 • 1.2 mm Hg, n = l l ,p  < 0.001). On the other hand, 
neither systolic systemic blood pressure nor systemic 
vascular esistance was affected by the operation. These 
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Fig. 1. ET-1 concentrations of 11 patients with pulmo- 
nary hypertension caused by CHD before and after suc- 
cessful surgical repair and ET-1 concentrations of six age- 
matched control subjects. Each point represents an 
individual plasma ET-1 value. Each horizontal line represents 
the mean of each group. Note that several points overlap. 
observations suggested that surgical repair markedly ame- 
liorated PH, pulmonary congestion, and complications 
that affected all the patients before the operation. Preop- 
erative plasma ET-1 levels of the patients with PH were 
significantly higher than those of age-matched control 
subjects (3.96 _ 0.53 pg/ml, n = 11, versus 1.63 • 0.13 
pg/ml, n = 6,p < 0.001, Fig. 1). The elevated ET-1 levels 
were markedly reduced 4 weeks after the operation 
(3.96 • 0.53 pg/ml to 1.98 • 0.14 pg/ml, n = l l ,p  < 0.001, 
Fig. 1). 
The present study demonstrated that successful surgery 
decreased the elevated plasma ET-1 levels in young 
patients with PH caused by CHD, indicating that the 
elevation of plasma ET-1 in these patients was reversible. 
In patients with PH caused by CHD, Yoshibayashi and 
colleagues s have indicated a significant step-up in plasma 
ET-1 concentrations in the pulmonary vein when com- 
pared with those in the right ventricle, and they suggested 
that ET-1 is released from the pulmonary circulation. It 
has also been demonstrated that expression of ET-1 
increased in the pulmonary vascular endothelial cells of 
patients with PH. 1~ Thtis the increase in ET-1 production 
in pulmonary circulation may be reflected, at least in part, 
on an increase in plasma ET-1 in patients with PH. Taken 
together, these observations eem to indicate that the 
pressure overload may injure the pulmonary vascular endo- 
thelial cells and hence lead to an elevation of ET-1 produc- 
tion in the patients with PH. Furthermore, the excessively 
produced ET-1 may aggravate the pulmonary hemodynam- 
ics through its potent and long-lasting vasoconstrictive as
well as proliferative actions on the pulmonary artery. After 
surgery, in turn, these pathophysiologic conditions of pulmo- 
nary circulation may be ameliorated in a reverse direction. 
The present findings suggest that the extent of increase 
in plasma ET-1 levels in patients with PH may reflect the 
abnormalities of pulmonary circulation. Because lectron 
microscopic study has demonstrated that the pulmonary 
artery endothelial cells are injured in patients with PH 
caused by CHD, 11 it is likely that a successful operation 
might ameliorate ndothelial injuries, thereby reducing 
the elevated production of ET-1 in pulmonary vascular 
endothelial cells. We consider, therefore, that the im- 
proved conditions of pulmonary vascular endothelial cells 
may play an important role in ameliorating the clinical 
symptoms in the patients with PH caused by CHD after 
successful operations. 
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PERCUTANEOUS THORACOSTOMY WITH PLASTIC-SHIELDED LOCKING TROCAR 
Ilan Ben Ze'ev, MD, Holon, Israel 
Thoracostomy is a common procedure in trauma, gen- 
eral, and thoracic surgery. The traditional approach for 
this is insertion of a massive wire guide covered with a 
tube into the chest cavity. There have been many reports 
about injuries to organs, such as lungs, heart, and vessels, 
caused by the wire. This technique has therefore been 
controversial, and finally the ATLS committee recom- 
mended "open insertion," without a guide. 
We would like to present a new, easier, and safer tech- 
nique of chest tube insertion with the surgical shielded 
trocar. We looked for a method that combines the advan- 
tages of the two approaches, the simplicity of the wire guide 
and the safety of the open thoracostomy. Percutaneous 
thoracostomy with a locking trocar that has a plastic safety 
shield seems to fulfill these requirements he most. 
The shielded trocar has been in use for many years in 
gynecologic surgery. With the development of thoraco- 
scopic and laparoscopic techniques, it became more 
widely used for general and thoracic surgery. Shielded 
trocars are presently available in all hospitals: 
After taking these factors into account, we started in our 
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surgical department to use a surgical trocar to insert chest 
tubes. The technique isconducted as follows: A 1 cm incision 
is made with the patient under local anesthesia. A 10 mm 
trocar (AutoSuture, Surgiport Disposable Surgical Trocar; 
U.S. Surgical Corp., Norwalk, Conn.) is introduced. The 
trocar is equipped with a spring mechanism that allows the 
plastic sheath to move forward once the chest cavity has been 
entered by the introducer. The trocar is then removed from 
the introducer, and a 28F chest ube is passed into the chest 
cavity through the introducer. Once the tube is in place, the 
introducer is removed. With this technique, we have placed 
chest ubes in more than 100 patients who were referred to 
us because of pleural effusion, pneumothorax, hemopneu- 
mothorax, or empyema. 
The percutaneous thoracostomy with locking trocar 
method has the following advantages: (1) Insertion 
through the chest wall is much faster and therefore less 
traumatic to the patient. (2) The spring mechanism akes 
this method much safer with regard to injury to organs; no 
other complications were observed. (3) Percutaneous 
thoracotomy with locking trocar is a simple procedure that 
can be performed safely by less experienced staff mem- 
bers, for example, in emergency care. In our department, 
junior physicians are able to perform this procedure 
independently after being trained in vivo in the operating 
room under supervision. 
We recommend this technique for routine use in chest 
tube insertion. 
A NEW TECHNIQUE FOR ONE-LUNG VENTILATION DURING VIDEO-ASSISTED 
THORACOSCOPIC SURGICAL INTERRUPTION OF PATENT DUCTUS ARTERIOSUS IN CHILDREN 
Mahesh Vakamudi, MD, Venkataraya Shenoy, MD, Jagannath Haldar, MD, Mahadev Dixit, DipNB, S. Bagchi, and 
Devi Shetty, Calcutta, India 
Video-assisted thoracoscopic surgical interruption of 
patent ductus arteriosus was first reported by Laborde and 9 
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associates. 1 Recently we did five cases of patent ductus 
arteriosus interruption using a video-assisted thoraco- 
scope. We found that the use of one-lung ventilation 
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